{
    "xml": "<topic id=\"PHP93592\" outputclass=\"drug\" rev=\"1.10\" type=\"drug\" namespace=\"/drugs/lurasidone-hydrochloride\" basename=\"lurasidone-hydrochloride\" title=\"LURASIDONE HYDROCHLORIDE\">\n<title>LURASIDONE HYDROCHLORIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1346\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/lurasidone\">Lurasidone</xref>\n</p>\n<data name=\"vtmid\">26664311000001101</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_358387308\" title=\"Antipsychotics (second-generation)\">Antipsychotics (second-generation)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP93801\" outputclass=\"drugAction\" rev=\"1.11\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Lurasidone is a dopamine D<sub>2</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>7</sub>, alpha<sub>2A</sub>- and alpha<sub>2C</sub>- adrenoceptor antagonist, and is a partial agonist at 5-HT<sub>1a</sub> receptors.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93804\" outputclass=\"indicationsAndDose\" rev=\"1.30\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Schizophrenia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 37&#8239;mg once daily, increased if necessary up to 148&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Schizophrenia when given with concomitant moderate CYP3A4 inhibitors (e.g. diltiazem, erythromycin, fluconazole, and verapamil)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 18.5&#8239;mg once daily (max. per dose 74&#8239;mg once daily).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>Initially 18.5&#8239;mg once daily, up to max. 74&#8239;mg once daily with concomitant moderate CYP3A4 inhibitors (e.g. diltiazem, erythromycin, fluconazole, and verapamil.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93797\" outputclass=\"cautions\" rev=\"1.13\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">High doses in elderly</ph>; <ph outputclass=\"caution\">susceptibility to QT-interval prolongation</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93805\" outputclass=\"interactions\" rev=\"1.13\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Contra-indicated with concomitant use of potent CYP3A4 inhibitors.</p>\n<p>Contra-indicated with concomitant use of potent CYP3A4 inducers.</p>\n<p>Caution with concomitant use of drugs that prolong the QT interval.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93810\" outputclass=\"sideEffects\" rev=\"1.18\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anxiety</ph>; <ph outputclass=\"sideEffect\">musculoskeletal stiffness</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Catatonia</ph>; <ph outputclass=\"sideEffect\">decreased appetite</ph>; <ph outputclass=\"sideEffect\">dysarthria</ph>; <ph outputclass=\"sideEffect\">dysuria</ph>; <ph outputclass=\"sideEffect\">hot flush</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">nightmares</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Angina</ph>; <ph outputclass=\"sideEffect\">AV block</ph>; <ph outputclass=\"sideEffect\">bradycardia</ph>; <ph outputclass=\"sideEffect\">dysphagia</ph>; <ph outputclass=\"sideEffect\">panic attacks</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">suicidal behaviour</ph>; <ph outputclass=\"sideEffect\">vertigo</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93806\" outputclass=\"pregnancy\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use only if potential benefit outweighs risk&#8212;limited information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93796\" outputclass=\"breastFeeding\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>There is limited information available on the short- and long-term effects of antipsychotic drugs on the breast-fed infant.</p>\n<p>\n<i>Animal</i> studies indicate possible adverse effects of antipsychotic medicines on the developing nervous system.</p>\n<p>Chronic treatment with antipsychotic drugs whilst breast-feeding should be avoided unless absolutely necessary.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93803\" outputclass=\"hepaticImpairment\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Initially 18.5&#8239;mg once daily, up to max. 74&#8239;mg once daily in moderate impairment.</p>\n<p>Use with caution in severe impairment&#8212;initially 18.5&#8239;mg once daily, up to max. 37&#8239;mg once daily.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93808\" outputclass=\"renalImpairment\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Initially 18.5&#8239;mg once daily, up to max. 74&#8239;mg once daily if eGFR less than 50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n<p>Manufacturer advises use only if potential benefit outweighs risk if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93794\" outputclass=\"directionsForAdministration\" rev=\"1.9\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Patients on doses higher than 111&#8239;mg once daily whose treatment is interrupted for longer than 3 days should restart on 111&#8239;mg once daily and titrate to usual dose; for all other doses, restart on usual dose.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93592-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/lurasidone-hydrochloride\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101370\" title=\"Tablet\" namespace=\"/drugs/lurasidone-hydrochloride/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e63067\" href=\"#bnf_d1e63067\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/lurasidone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e63067</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e63103\" href=\"#bnf_d1e63103\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/lurasidone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e63103</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e63126\" href=\"#bnf_d1e63126\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/lurasidone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e63126</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e63385\" href=\"#bnf_d1e63385\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/lurasidone\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e63385</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e19570\" href=\"#bnf_d1e19570\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/erythromycin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e19570</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_169\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/macrolides/erythromycin\" title=\"Erythromycin\" count=\"1\" rel=\"backlink\">Erythromycin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e57037\" href=\"#bnf_d1e57037\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/fluconazole\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e57037</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_301\" namespace=\"/interactions/list-of-drug-interactions/antifungals/antifungals-triazole/fluconazole\" title=\"Fluconazole\" count=\"1\" rel=\"backlink\">Fluconazole</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e90923\" href=\"#bnf_d1e90923\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/verapamil\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e90923</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_467\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/verapamil\" title=\"Verapamil\" count=\"1\" rel=\"backlink\">Verapamil</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e90116\" href=\"#bnf_d1e90116\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/diltiazem\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e90116</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_468\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/diltiazem\" title=\"Diltiazem\" count=\"1\" rel=\"backlink\">Diltiazem</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1346\" namespace=\"/interactions/list-of-drug-interactions/antipsychotics/lurasidone\" title=\"Lurasidone\" count=\"1\" rel=\"link\">Lurasidone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101370\" namespace=\"/drugs/lurasidone-hydrochloride/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP93592",
    "outputclass": "drug",
    "rev": "1.10",
    "type": "drug",
    "namespace": "/drugs/lurasidone-hydrochloride",
    "basename": "lurasidone-hydrochloride",
    "title": "LURASIDONE HYDROCHLORIDE",
    "interactants": [
        {
            "id": "bnf_int_1346",
            "label": "Lurasidone"
        }
    ],
    "vtmid": "26664311000001101",
    "drugClassification": [
        "Antipsychotics (second-generation)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Lurasidone is a dopamine D2, 5-HT2A, 5-HT7, alpha2A- and alpha2C- adrenoceptor antagonist, and is a partial agonist at 5-HT1a receptors.",
                "html": "<p>Lurasidone is a dopamine D<sub>2</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>7</sub>, alpha<sub>2A</sub>- and alpha<sub>2C</sub>- adrenoceptor antagonist, and is a partial agonist at 5-HT<sub>1a</sub> receptors.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Schizophrenia",
                        "html": "Schizophrenia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 37 mg once daily, increased if necessary up to 148 mg once daily.",
                        "html": "<p>Initially 37&#8239;mg once daily, increased if necessary up to 148&#8239;mg once daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Schizophrenia when given with concomitant moderate CYP3A4 inhibitors (e.g. diltiazem, erythromycin, fluconazole, and verapamil)",
                        "html": "Schizophrenia when given with concomitant moderate CYP3A4 inhibitors (e.g. diltiazem, erythromycin, fluconazole, and verapamil)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 18.5 mg once daily (max. per dose 74 mg once daily).",
                        "html": "<p>Initially 18.5&#8239;mg once daily (max. per dose 74&#8239;mg once daily).</p>"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "Initially 18.5 mg once daily, up to max. 74 mg once daily with concomitant moderate CYP3A4 inhibitors (e.g. diltiazem, erythromycin, fluconazole, and verapamil.",
                "html": "<p>Initially 18.5&#8239;mg once daily, up to max. 74&#8239;mg once daily with concomitant moderate CYP3A4 inhibitors (e.g. diltiazem, erythromycin, fluconazole, and verapamil.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "High doses in elderly",
                "html": "High doses in elderly"
            },
            {
                "type": "cautions",
                "textContent": "susceptibility to QT-interval prolongation",
                "html": "susceptibility to QT-interval prolongation"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Contra-indicated with concomitant use of potent CYP3A4 inhibitors.\n\nContra-indicated with concomitant use of potent CYP3A4 inducers.\n\nCaution with concomitant use of drugs that prolong the QT interval.",
                "html": "<p>Contra-indicated with concomitant use of potent CYP3A4 inhibitors.</p><p>Contra-indicated with concomitant use of potent CYP3A4 inducers.</p><p>Caution with concomitant use of drugs that prolong the QT interval.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Anxiety",
                        "html": "Anxiety",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "musculoskeletal stiffness",
                        "html": "musculoskeletal stiffness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Catatonia",
                        "html": "Catatonia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "decreased appetite",
                        "html": "decreased appetite",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dysarthria",
                        "html": "dysarthria",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dysuria",
                        "html": "dysuria",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hot flush",
                        "html": "hot flush",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "nightmares",
                        "html": "nightmares",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Angina",
                        "html": "Angina",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "AV block",
                        "html": "AV block",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bradycardia",
                        "html": "bradycardia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dysphagia",
                        "html": "dysphagia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "panic attacks",
                        "html": "panic attacks",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "suicidal behaviour",
                        "html": "suicidal behaviour",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vertigo",
                        "html": "vertigo",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use only if potential benefit outweighs risk&#8212;limited information available.",
                "html": "<p>Use only if potential benefit outweighs risk&#8212;limited information available.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "There is limited information available on the short- and long-term effects of antipsychotic drugs on the breast-fed infant.\n\nAnimal studies indicate possible adverse effects of antipsychotic medicines on the developing nervous system.\n\nChronic treatment with antipsychotic drugs whilst breast-feeding should be avoided unless absolutely necessary.",
                "html": "<p>There is limited information available on the short- and long-term effects of antipsychotic drugs on the breast-fed infant.</p><p>\n<i>Animal</i> studies indicate possible adverse effects of antipsychotic medicines on the developing nervous system.</p><p>Chronic treatment with antipsychotic drugs whilst breast-feeding should be avoided unless absolutely necessary.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Initially 18.5 mg once daily, up to max. 74 mg once daily in moderate impairment.\n\nUse with caution in severe impairment&#8212;initially 18.5 mg once daily, up to max. 37 mg once daily.",
                "html": "<p>Initially 18.5&#8239;mg once daily, up to max. 74&#8239;mg once daily in moderate impairment.</p><p>Use with caution in severe impairment&#8212;initially 18.5&#8239;mg once daily, up to max. 37&#8239;mg once daily.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Initially 18.5 mg once daily, up to max. 74 mg once daily if eGFR less than 50 mL/minute/1.73 m2.\n\nManufacturer advises use only if potential benefit outweighs risk if eGFR less than 15 mL/minute/1.73 m2.",
                "html": "<p>Initially 18.5&#8239;mg once daily, up to max. 74&#8239;mg once daily if eGFR less than 50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p><p>Manufacturer advises use only if potential benefit outweighs risk if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Patients on doses higher than 111 mg once daily whose treatment is interrupted for longer than 3 days should restart on 111 mg once daily and titrate to usual dose; for all other doses, restart on usual dose.",
                "html": "<p>Patients on doses higher than 111&#8239;mg once daily whose treatment is interrupted for longer than 3 days should restart on 111&#8239;mg once daily and titrate to usual dose; for all other doses, restart on usual dose.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP101370",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "#bnf_d1e63067": [
            {
                "id": "bnf_d1e63067",
                "label": "bnf_d1e63067",
                "type": "#bnf_d1e63067"
            }
        ],
        "#bnf_d1e63103": [
            {
                "id": "bnf_d1e63103",
                "label": "bnf_d1e63103",
                "type": "#bnf_d1e63103"
            }
        ],
        "#bnf_d1e63126": [
            {
                "id": "bnf_d1e63126",
                "label": "bnf_d1e63126",
                "type": "#bnf_d1e63126"
            }
        ],
        "#bnf_d1e63385": [
            {
                "id": "bnf_d1e63385",
                "label": "bnf_d1e63385",
                "type": "#bnf_d1e63385"
            }
        ],
        "#bnf_d1e19570": [
            {
                "id": "bnf_d1e19570",
                "label": "bnf_d1e19570",
                "type": "#bnf_d1e19570"
            }
        ],
        "interaction": [
            {
                "id": "bnf_int_169",
                "label": "Erythromycin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_301",
                "label": "Fluconazole",
                "type": "interaction"
            },
            {
                "id": "bnf_int_467",
                "label": "Verapamil",
                "type": "interaction"
            },
            {
                "id": "bnf_int_468",
                "label": "Diltiazem",
                "type": "interaction"
            }
        ],
        "#bnf_d1e57037": [
            {
                "id": "bnf_d1e57037",
                "label": "bnf_d1e57037",
                "type": "#bnf_d1e57037"
            }
        ],
        "#bnf_d1e90923": [
            {
                "id": "bnf_d1e90923",
                "label": "bnf_d1e90923",
                "type": "#bnf_d1e90923"
            }
        ],
        "#bnf_d1e90116": [
            {
                "id": "bnf_d1e90116",
                "label": "bnf_d1e90116",
                "type": "#bnf_d1e90116"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1346",
                "label": "Lurasidone",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP101370",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}